Use of a recombinant Trypanosoma cruzi protein antigen to monitor cure of Chagas disease.
Guevara
A G
AG
Centre d'Immunologie et de Biologie Parasitaire, INSERM Unité 415, Institut Pasteur-Lille, France.
Taibi
A
A
Alava
J
J
Guderian
R H
RH
Ouaissi
A
A
D000208:Acute Disease; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000953:Antigens, Protozoan; D014355:Chagas Disease / Q000188:drug therapy* / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D005455:Fluorescent Antibody Technique; D006801:Humans; D009593:Nitroimidazoles / Q000627:therapeutic use; D011994:Recombinant Proteins; D014344:Trypanocidal Agents / Q000627:therapeutic use; D014349:Trypanosoma cruzi / Q000276:immunology*
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D009593:Nitroimidazoles; D011994:Recombinant Proteins; D014344:Trypanocidal Agents; C009999:benzonidazole